Pediatrix Medical Group Reports First Quarter Results
Pediatrix Medical Group reported Q1 revenue of $476.2 million and Adjusted EPS of $0.44, exceeding internal expectations driven by top-line growth and same-unit revenue increases of 2.8%. Adjusted EBITDA rose 18% year-over-year to $58.2 million, supported by recent acquisitions and improved reimbursements, though same-unit patient volume dipped slightly.
Key figures
- Eps
- 0.44
- Revenue
- $476.2 million
- Guidance
- 2026 Adjusted EBITDA $280 million to $300 million
- Net income
- $29.6 million
- Adjusted ebitda
- $58.2 million
- Share repurchases
- $21.5 million
- Cash used in operations
- $129.5 million
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.